WOBURN, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has submitted a De Novo request to the U.S. Food and Drug Administration (FDA) for Quell as a ...

PITTSBURGH--(BUSINESS WIRE)--Swing Therapeutics announced that Stanza, its digital therapeutic for treatment of fibromyalgia symptoms, has received a positive coverage decision from Highmark Health.

Fibromyalgia is a chronic condition which can cause widespread pain and profound fatigue. The name is made up of “fibro” for fibrous tissues such as tendons and ligaments, “my” indicating muscles, and ...

Tilray Brands announced on Monday a new scientific publication supported by Tilray Medical. The study examines the real-world impact of cannabinoid treatments on patients with fibromyalgia. The study ...

Depression relief was the primary driver of disease improvement among patients with fibromyalgia and prominent anxiety and depression symptoms.

Fibromyalgia In patients with concomitant fibromyalgia and PTSD, opioid therapy was shown to improve quality of life and help patients return to a greater sense of "normalcy." The following article ...

CHATHAM, NEW JERSEY / ACCESS Newswire / March 31, 2025 / This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp.

Treatment with TONMYA provided statistically significant pain reduction in two Phase 3 trials and was generally well tolerated BERKELEY HEIGHTS, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- Tonix ...

Fibromyalgia (FMS) and chronic fatigue syndrome (CFS), also called myalgic encephalomyelitis (ME/CFS), are chronic conditions ...

Company launched TONMYA, approved by the FDA as a treatment for fibromyalgia, in November 2025In post hoc analysis of the pivotal RESILIENT ...

Between four and 10 million people in the U.S. have fibromyalgia. Many doctors look askance at the disorder, leading some ...